Gilead Sciences Non-US — Property, plant and equipment, net increased by 0.6% to $631.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $627.00M to $631.00M.
An increase suggests expansion of international manufacturing or research capabilities, while a decrease may indicate divestment, asset optimization, or the outsourcing of international production.
This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...
Peers in the pharmaceutical industry typically report this as part of geographic segment disclosures, with variations based on the extent of their global manufacturing footprint versus reliance on contract manufacturing organizations.
gild_segment_non_us_property_plant_and_equipment_net| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $963.00M | $973.00M | $626.00M | $627.00M | $631.00M |
| QoQ Change | — | +1.0% | -35.7% | +0.2% | +0.6% |
| YoY Change | — | +1.0% | -35.7% | +0.2% | +0.6% |